Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
10Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Aura Biosciences, Inc. (AURA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
18Total relationships
2Distinct source URLs
5High confidence
0.758Average confidence
2026-10-29Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Aura Biosciences, Inc. Suppliers
Ticker
Name
Confidence
Evidence
THIRD-PARTY-CROS
THIRD-PARTY-CROS
90%
We utilize third-party CROs and/or regulatory consultants to assist us in the regulatory approval process globally
Reciprocal relationship from ENGN graph: Reciprocal relationship from AURA graph: Reciprocal relationship from ENGN graph: Reciprocal relationship from AURA graph: Reciprocal relationship from ENGN g…
Reciprocal relationship from ENGNW graph: Reciprocal relationship from AURA graph: Reciprocal relationship from ENGNW graph: Reciprocal relationship from AURA graph: Reciprocal relationship from ENGN…
COMPETITORS
COMPETITORS
70%
including shortages caused by the purchase of such raw materials or API, by our competitors or others
rts of such third parties, which may not be successful. Further, if we enter into arrangements with third parties to perform sales and marketing services, our product revenues, if any, may be lower t…
Reciprocal relationship from CGON graph: Reciprocal relationship from AURA graph: rts of such third parties, which may not be successful. Further, if we enter into arrangements with third parties to …
Reciprocal relationship from ENGN graph: Reciprocal relationship from AURA graph: Reciprocal relationship from ENGN graph: Reciprocal relationship from AURA graph: Reciprocal relationship from ENGN g…
Reciprocal relationship from ENGNW graph: nts, drug substance and drug product are currently manufactured at cGMP-compliant CMOs at a scale that we believe can meet our needs for a commercial launch …
rts of such third parties, which may not be successful. Further, if we enter into arrangements with third parties to perform sales and marketing services, our product revenues, if any, may be lower t…
Reciprocal relationship from JNJ graph: Reciprocal relationship from AURA graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from AURA graph: Reciprocal relationship from JNJ grap…
rts of such third parties, which may not be successful. Further, if we enter into arrangements with third parties to perform sales and marketing services, our product revenues, if any, may be lower t…
Reciprocal relationship from URGN graph: Reciprocal relationship from AURA graph: Reciprocal relationship from URGN graph: Reciprocal relationship from AURA graph: Reciprocal relationship from URGN g…
EMERGING-GROWTH-COMPANY
EMERGING-GROWTH-COMPANY
62%
third-party and government payors; ▪ the effect of competing technological and market developments; ▪ the extent to which we acquire or invest in businesses, products, and technologies; and ▪ unfavor…
JOHNSON-UROGEN-PHARMA-LTD-CG-ONCOLOGY-INC-IMMUNI
JOHNSON-UROGEN-PHARMA-LTD-CG-ONCOLOGY-INC-IMMUNI
62%
rts of such third parties, which may not be successful. Further, if we enter into arrangements with third parties to perform sales and marketing services, our product revenues, if any, may be lower t…
Aura Biosciences, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
AURA-DEBT
Debt stack $17.0M
90%
Market cache reports total debt of $17.0M.
AURA-DEBT-7977
Warrants outstanding: 7373185
90%
xbrl warrant detail from xbrl 2026-03-31.
AURA-DEBT-7978
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2021-12-31.
Aura Biosciences, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Aura Biosciences, Inc..
Aura Biosciences, Inc. Ownership
Holder
Name
Confidence
Evidence
AURA-OWNER-MATRIX-CAPITAL-MANAGEMENT-COMPAN
Matrix Capital Management Company, LP
90%
13F overlay lists Matrix Capital Management Company, LP as top holder; 127 tracked holders.
Aura Biosciences, Inc. Extended Supply Chain Network
